Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALML3 | P27482 | 5/20 | 0.56 |
| ▸ | MAOB | P27338 | 10/20 | 0.52 |
| ▸ | MAOA | P21397 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | SDHA | P31040 | 1/20 | 0.52 |
| ▸ | F10 | P00742 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13404013 | 0.90 | MAOB (0.49) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28110345 | 0.89 | MAOB (0.58) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28428084 | 0.89 | MAOB (0.58) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL6525428 | 0.86 | MAOA (0.73) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL29196827 | 0.85 | CALML3 (0.55) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL29196830 | 0.85 | CALML3 (0.55) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL14580096 | 0.84 | CALML3 (0.57) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28109794 | 0.84 | CALML3 (0.65) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL14898018 | 0.84 | CALML3 (0.61) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL7493173 | 0.83 | MAOB (0.62) | CALML3MAOBMAOALMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050118624-A1 | Fluorescent probes for ribosomes and method of use | CUMBRE INC. (US) | 2005-06-02 | — | — | US | disclosed |
| WO-2005036169-A2 | FLUORESCENT PROBES FOR RIBOSOMES AND METHOD OF USE | CUMBRE INC. (US) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050118624-A1 | Fluorescent probes for ribosomes and method of use | MRPS27, NOP2, RPL30 | CALML3 2280/4885MAOB 4549/4885MAOA 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.